These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33534843)

  • 1. Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP+ in dissociated cultures from rat mesencephalon.
    Jaumotte JD; Saarma M; Zigmond MJ
    PLoS One; 2021; 16(2):e0245663. PubMed ID: 33534843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of cultured dopamine neurons from MPP(+) requires a combination of neurotrophic factors.
    Jaumotte JD; Wyrostek SL; Zigmond MJ
    Eur J Neurosci; 2016 Jul; 44(1):1691-9. PubMed ID: 27098376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM; Jaumotte JD; Signore AP; Zigmond MJ
    J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
    Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures.
    Jaumotte JD; Zigmond MJ
    J Neurosci Res; 2014 Nov; 92(11):1425-33. PubMed ID: 24916473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
    Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JWH133 attenuates behavior deficits and iron accumulation in 6-OHDA-induced Parkinson's disease model rats.
    Liu M; Pan D; Wang M; Deng H; Ma Z
    J Neurophysiol; 2024 Sep; 132(3):733-743. PubMed ID: 39015077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
    Huang JY; Hong YT; Chuang JI
    J Neurochem; 2009 Jun; 109(5):1400-12. PubMed ID: 19476551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
    Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
    Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration.
    Galpern WR; Frim DM; Tatter SB; Altar CA; Beal MF; Isacson O
    Cell Transplant; 1996; 5(2):225-32. PubMed ID: 8689033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
    Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
    J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.
    Airavaara M; Harvey BK; Voutilainen MH; Shen H; Chou J; Lindholm P; Lindahl M; Tuominen RK; Saarma M; Hoffer B; Wang Y
    Cell Transplant; 2012; 21(6):1213-23. PubMed ID: 21943517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociated high-purity dopaminergic neuron cultures from the substantia nigra and the ventral tegmental area of the postnatal rat.
    Masuko S; Nakajima S; Nakajima Y
    Neuroscience; 1992 Jul; 49(2):347-64. PubMed ID: 1359454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
    Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
    Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
    Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X
    Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
    Mena MA; Casarejos MJ; García de Yébenes J
    J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.
    Voutilainen MH; De Lorenzo F; Stepanova P; Bäck S; Yu LY; Lindholm P; Pörsti E; Saarma M; Männistö PT; Tuominen RK
    eNeuro; 2017; 4(1):. PubMed ID: 28303260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.